For the treatment of infections in which anaerobic bacteria have been identified or are suspected as pathogens, particularly Bacteroides fragilis and other species of bacteroides and including other species for which metronidazole is bactericidal. For the prevention of post-operative abdominal and pelvic infections due to anaerobic bacteria.